Breathett Khadijah, Willis Shannon, Foraker Randi E, Smith Sakima
Division of Cardiology, University of Colorado Anschutz Medical Center, Aurora, Colorado.
Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Heart Lung Circ. 2017 Feb;26(2):164-171. doi: 10.1016/j.hlc.2016.05.123. Epub 2016 Jul 18.
Heart transplantation allocation is often restricted from patients with low socioeconomic status (SES) due to concern for worse outcomes. We hypothesised that comorbidities would have a greater impact on risk of severe rejection post-orthotopic heart transplant than would Medicaid insurance and Median Household Income (MHI).
A retrospective study of 171 patients who underwent orthotopic heart transplant between 7/1999-11/2013 at our facility were followed until 9/2014 for rejection hospitalisations or death. Survival and multivariable analyses with adjustment for age, race, and gender were performed to estimate the risk of severe cellular rejection, ≥2r (hazard ratio [HR], 95% confidence interval [CI]).
Eighteen per cent of patients had Medicaid, and 72% of patients had low or medium MHI. Severe rejection occurred in 23% of patients. In the univariable analysis, Medicaid and diabetes were associated with increased risk of rejection while age >60 years, Caucasian race, and male sex were associated with reduced risk [Medicaid 2.32(1.20,4.51), diabetes 2.49(1.09,5.69), age 0.41(0.20,0.84), Caucasian 0.44(0.21,0.93), male 0.49(0.26,0.92)]. Median Household Income had no correlation [MHI 0.79(0.51,1.23)]. In the multivariable adjusted model, Medicaid was not associated with rejection [1.65(0.79,3.41)]; diabetes was strongly associated with risk of severe rejection [3.9(1.59,9.39)], and age >60 years was associated with risk reduction [0.42(0.20,0.82)].
Medicaid insurance and MHI were not associated with increased risk of severe cellular rejection requiring hospitalisation post-orthotopic heart transplant in the adjusted model. Rather the presence of diabetes and age ≤60 years were associated with increased risk.
由于担心预后较差,心脏移植分配通常会将社会经济地位较低(SES)的患者排除在外。我们假设,与医疗补助保险和家庭收入中位数(MHI)相比,合并症对原位心脏移植后发生严重排斥反应的风险影响更大。
对1999年7月至2013年11月在我们机构接受原位心脏移植的171例患者进行回顾性研究,随访至2014年9月,观察排斥反应住院或死亡情况。进行生存分析和多变量分析,并对年龄、种族和性别进行调整,以估计严重细胞排斥反应(≥2r)的风险(风险比[HR],95%置信区间[CI])。
18%的患者有医疗补助,72%的患者MHI低或中等。23%的患者发生了严重排斥反应。在单变量分析中,医疗补助和糖尿病与排斥反应风险增加相关,而年龄>60岁、白种人和男性与风险降低相关[医疗补助2.32(1.20,4.51),糖尿病2.49(1.09,5.69),年龄0.41(0.20,0.84),白种人0.44(0.21,0.93),男性0.49(0.26,0.92)]。家庭收入中位数无相关性[MHI 0.79(0.51,1.23)]。在多变量调整模型中,医疗补助与排斥反应无关[1.65(0.79,3.41)];糖尿病与严重排斥反应风险密切相关[3.9(1.59,9.39)],年龄>60岁与风险降低相关[0.42(0.20,0.82)]。
在调整模型中,医疗补助保险和MHI与原位心脏移植后需要住院治疗的严重细胞排斥反应风险增加无关。相反,糖尿病的存在和年龄≤60岁与风险增加相关。